Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The PRiME Study: PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03299309
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:36.748938+00:00
Published At
2025-07-09T00:00:00+00:00
Record Updated At
2025-07-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Medulloblastoma", "Recurrent Brain Tumor, Childhood", "Malignant Glioma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-07-09"
protocolSection.identificationModule.nctId
"NCT03299309"
protocolSection.identificationModule.officialTitle
"The PRiME Study: PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Recurrent Medulloblastoma (protocolSection.conditionsModule.conditions)
  • Recurrent Brain Tumor, Childhood (protocolSection.conditionsModule.conditions)
  • Malignant Glioma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.